HWA
JAZZ icon

Heritage Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Heritage Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8
Closed -$984 – 558
2023
Q4 		$984 Hold
8
– – ﹤0.01% 516
2023
Q3 		$1.04K Hold
8
– – ﹤0.01% 475
2023
Q2 		$992 Hold
8
– – ﹤0.01% 515
2023
Q1 		$1.17K Hold
8
– – ﹤0.01% 526
2022
Q4 		$1.27K Hold
8
– – ﹤0.01% 517
2022
Q3 		$1.07K Hold
8
– – ﹤0.01% 495
2022
Q2 		$1K Hold
8
– – ﹤0.01% 539
2022
Q1 		$1K Hold
8
– – ﹤0.01% 518
2021
Q4 		$1K Hold
8
– – ﹤0.01% 525
2021
Q3 		$1.04K Hold
8
– – ﹤0.01% 511
2021
Q2 		$1.42K Buy
8
+3
+60% +$520 ﹤0.01% 520
2021
Q1 		$822 Buy
+5
New +$823 ﹤0.01% 543

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Heritage Wealth Advisors's JAZZ Position: Q1 2024 in Review

Heritage Wealth Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 8 shares — an estimated $984 sold.

Heritage Wealth Advisors first reported a position in JAZZ in Q1 2021 and held it in 12 quarters. The position peaked at $1.42K in Q2 2021. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

  • Heritage Wealth Advisors reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Heritage Wealth Advisors sold 8 Jazz Pharmaceuticals shares in Q1 2024, an estimated $984.
  • Heritage Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q1 2021 and held it in 12 quarters.
  • Heritage Wealth Advisors's Jazz Pharmaceuticals position peaked at $1.42K in Q2 2021.
  • 481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on Heritage Wealth Advisors's 13F filing for Q1 2024, filed 8 May 2024.